Bo Stentoft ApS: Financial statements 2025
CVR: 35842594
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Bo Stentoft ApS (CVR 35842594) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 683,718 and a net result of DKK 249,774 compared with DKK 52,623 the year before. That is an increase of 265.5% compared with the year before. Equity in the 2025 report amounted to DKK 119,403. The solvency ratio was 27.8%.
- Gross Profit
- DKK 683,718
- Profit/Loss
- DKK 249,774
- Equity
- DKK 119,403
- Total Assets
- DKK 429,831
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 684 t. | 250 t. | 119 t. | - |
| 2024 | - | 187 t. | 53 t. | -130 t. | - |
| 2023 | - | 3 t. | -5 t. | -183 t. | - |
| 2022 | - | 127 t. | 62 t. | -178 t. | - |
| 2021 | - | 113 t. | 85 t. | -243 t. | 0 |
Official annual report
How creditworthy is Bo Stentoft ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Bo Stentoft ApS has published its annual report for 2024. Gross profit came to DKK 187,064, and the net result was DKK 52,623.
About Bo Stentoft ApS
Bo Stentoft ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2014. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Cupping.dk ApS and ACUCARE ApS. The management consists of Bo Stentoft Jensen. The company is owned by Bo Stentoft Jensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 683,718 and a net result of DKK 249,774 compared with DKK 52,623 the year before. Equity in the 2025 report amounted to DKK 119,403.